>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

October 13, 2014

FDA MedWatch - ICU Medical ConMed Stat2 Flow Controller: Class 1 Recall - Delivers Higher Flow Rate than Intended

Summary:

FDA MedWatch ICU Medical ConMed Stat2 Flow Controller

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Company Model

Under the company model, referring physicians, who typically also own the facility where surgical procedures are performed, form a separate anesthesia company in order to share in anesthesia revenue.

ASA has serious concerns about the impact of the company model, and variations of that arrangement, on anesthesiologists, the patients they serve, and the integrity and fiscal soundness of Federal health care programs.  ASA has consistently advocated against company model arrangements.

ASA Urges Issuance of Federal Fraud Alert on the 'Company Model' (February 26, 2014)

Review HHS-OIG Advisory Opinion No. 13-15 (November 12, 2013)

ASA Requests Information on Company Model Arrangements (October 29, 2013)

Review ASA's formal comments to HHS-OIG Inspector General Levinson dated February 26, 2013.

Review the HHS-OIG Notice (February 26, 2013).

Review ASA's formal communication to Inspector General Levinson dated February 27, 2012.

Review the updated Company Model FAQ (August 20, 2012).

Watch the Special Company Model Webinar Presentation (June 22, 2012).

Review the HHS-OIG Advisory Opinion (June 1, 2012)